NO20013560L - Polymorfer av telmisartan, fremgangsmåter for fremstilling derav og anvendelse derav for fremstilling av et medikament - Google Patents

Polymorfer av telmisartan, fremgangsmåter for fremstilling derav og anvendelse derav for fremstilling av et medikament

Info

Publication number
NO20013560L
NO20013560L NO20013560A NO20013560A NO20013560L NO 20013560 L NO20013560 L NO 20013560L NO 20013560 A NO20013560 A NO 20013560A NO 20013560 A NO20013560 A NO 20013560A NO 20013560 L NO20013560 L NO 20013560L
Authority
NO
Norway
Prior art keywords
telmisartan
polymorphs
drug
manufacture
preparation
Prior art date
Application number
NO20013560A
Other languages
English (en)
Other versions
NO319823B1 (no
NO20013560D0 (no
Inventor
Heinric Schneider
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20013560D0 publication Critical patent/NO20013560D0/no
Publication of NO20013560L publication Critical patent/NO20013560L/no
Publication of NO319823B1 publication Critical patent/NO319823B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
NO20013560A 1999-01-19 2001-07-18 Polymorfer av telmisartan, fremgangsmater for fremstilling derav og anvendelse derav for fremstilling av et medikament NO319823B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19901921A DE19901921C2 (de) 1999-01-19 1999-01-19 Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels
PCT/EP2000/000065 WO2000043370A1 (de) 1999-01-19 2000-01-07 Polymorphe von telmisartan, verfahren zu deren herstellung und deren verwendung zur herstellung eines arzneimittels

Publications (3)

Publication Number Publication Date
NO20013560D0 NO20013560D0 (no) 2001-07-18
NO20013560L true NO20013560L (no) 2001-09-18
NO319823B1 NO319823B1 (no) 2005-09-19

Family

ID=7894715

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013560A NO319823B1 (no) 1999-01-19 2001-07-18 Polymorfer av telmisartan, fremgangsmater for fremstilling derav og anvendelse derav for fremstilling av et medikament

Country Status (36)

Country Link
EP (1) EP1144386B1 (no)
JP (1) JP4700813B2 (no)
KR (1) KR100658959B1 (no)
CN (1) CN1144790C (no)
AR (1) AR035475A1 (no)
AT (1) ATE252564T1 (no)
AU (1) AU765081B2 (no)
BG (1) BG65027B1 (no)
BR (1) BR0007584A (no)
CA (1) CA2352436C (no)
CO (1) CO5150238A1 (no)
CZ (1) CZ297412B6 (no)
DE (2) DE19901921C2 (no)
DK (1) DK1144386T3 (no)
EA (1) EA003065B1 (no)
EE (1) EE04344B1 (no)
ES (1) ES2208265T3 (no)
HK (1) HK1041485B (no)
HR (1) HRP20010514B1 (no)
HU (1) HU227401B1 (no)
IL (2) IL143634A0 (no)
MY (1) MY122755A (no)
NO (1) NO319823B1 (no)
NZ (1) NZ513528A (no)
PE (1) PE20001362A1 (no)
PL (1) PL211829B1 (no)
PT (1) PT1144386E (no)
RS (1) RS50044B (no)
SA (1) SA99200838B1 (no)
SK (1) SK285429B6 (no)
TR (1) TR200102074T2 (no)
TW (1) TWI280241B (no)
UA (1) UA56358C2 (no)
UY (1) UY25980A1 (no)
WO (1) WO2000043370A1 (no)
ZA (1) ZA200104771B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737432B2 (en) 2001-10-31 2004-05-18 Boehringer Ingelheim Pharma Kg Crystalline form of telmisartan sodium
DE10153737A1 (de) * 2001-10-31 2003-05-28 Boehringer Ingelheim Pharma Kristallines Natriumsalz des Telmisartans, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
PT1467712E (pt) * 2002-01-16 2008-01-09 Boehringer Ingelheim Pharma Comprimido farmacêutico de duas camadas compreendendo telmisartan e hidroclorotiazida
DE10314702A1 (de) * 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von Telmisartan
GB2414019A (en) * 2004-05-11 2005-11-16 Cipla Ltd One-step preparation of telmisartan by condensation and hydrolysis
CN101039917A (zh) 2004-10-15 2007-09-19 特瓦制药工业有限公司 制备替米沙坦的方法
WO2006044754A2 (en) 2004-10-18 2006-04-27 Dr. Reddy's Laboratories Ltd. Process for preparing telmisartan
US8637078B2 (en) 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
ES2598490T3 (es) 2009-05-20 2017-01-27 Boehringer Ingelheim Vetmedica Gmbh Disolución farmacéutica bebible de telmisartán
WO2010146187A2 (en) 2009-06-19 2010-12-23 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of telmisartan
EP2277866A1 (en) 2009-06-22 2011-01-26 Inke, S.A. Process for preparing telmisartan
WO2011002425A2 (en) 2009-07-02 2011-01-06 Bilgig Mahmut Pharmaceutical composition increasing solubility and stability
WO2011002423A2 (en) 2009-07-02 2011-01-06 Mahmut Bilgic Solubility enhancing pharmaceutical composition
WO2012055941A1 (en) 2010-10-27 2012-05-03 Krka,Tovarna Zdravil, D. D., Novo Mesto Multilayer pharmaceutical composition comprising telmisartan and amlodipine
ITMI20102416A1 (it) * 2010-12-27 2012-06-28 Chemelectiva S R L Intermedio per la preparazione di un principio attivo e processo per la sua preparazione
EP2612658A1 (en) 2012-01-05 2013-07-10 Laboratorios Lesvi, S.L. Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide
JP6147546B2 (ja) * 2013-04-10 2017-06-14 株式会社トクヤマ 酢酸が低減されたテルミサルタンａ型結晶の製造方法
EP2979691A1 (en) 2014-07-30 2016-02-03 Boehringer Ingelheim International GmbH Oral disintegrating tablet
JP6275596B2 (ja) * 2014-09-03 2018-02-07 株式会社トクヤマ テルミサルタンのアンモニウム塩の製造方法
JP5871294B1 (ja) 2015-02-27 2016-03-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 即時放出経口錠剤
KR20170001921A (ko) 2015-06-26 2017-01-05 대원제약주식회사 안정성이 개선된 텔미사르탄을 함유하는 약제학적 조성물 및 이의 제조방법
KR20170012703A (ko) 2015-07-22 2017-02-03 대원제약주식회사 텔미사르탄을 함유하는 약제학적 조성물 및 이의 제조방법
EP3463309B1 (en) 2016-05-30 2020-06-17 Boehringer Ingelheim International GmbH Fixed dose combination of telmisartan, hydrochlorothiazide and amlodipine
KR102044223B1 (ko) * 2016-09-12 2019-11-13 성균관대학교산학협력단 텔미사르탄을 포함하는 고체 분산체 및 이의 제조방법
CN106749036B (zh) * 2016-12-21 2019-06-21 山东大学 一种无定型的替米沙坦-庚二酸共晶及其制备方法和应用
CN106749037B (zh) * 2016-12-21 2019-06-21 山东大学 一种无定型的替米沙坦-戊二酸共晶及其制备方法和应用
WO2019008077A1 (en) 2017-07-07 2019-01-10 Boehringer Ingelheim Vetmedica Gmbh ANTAGONIST OF THE ANGIOTENSIN II RECEPTOR FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS
CN109851562A (zh) * 2019-01-30 2019-06-07 浙江省食品药品检验研究院 一种替米沙坦晶体及其制备方法
WO2023001880A1 (en) 2021-07-22 2023-01-26 Krka, D. D., Novo Mesto Bilayer tablet comprising telmisartan and indapamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9210098B (sl) * 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
US5139114A (en) * 1991-03-18 1992-08-18 Abex Corporation Visible brake block wear indicator

Also Published As

Publication number Publication date
PL349425A1 (en) 2002-07-29
ATE252564T1 (de) 2003-11-15
IL143634A0 (en) 2002-04-21
MY122755A (en) 2006-05-31
HRP20010514A2 (en) 2002-08-31
EE200100375A (et) 2002-10-15
PE20001362A1 (es) 2000-12-15
BR0007584A (pt) 2001-11-06
CN1336920A (zh) 2002-02-20
RS50044B (sr) 2008-11-28
ES2208265T3 (es) 2004-06-16
ZA200104771B (en) 2002-12-02
HK1041485A1 (en) 2002-07-12
YU51101A (sh) 2004-05-12
DE19901921C2 (de) 2001-01-04
DE50004150D1 (de) 2003-11-27
DK1144386T3 (da) 2004-01-12
AU2288100A (en) 2000-08-07
HUP0105148A2 (hu) 2002-07-29
AR035475A1 (es) 2004-06-02
SK285429B6 (sk) 2007-01-04
EA200100730A1 (ru) 2002-02-28
UY25980A1 (es) 2001-08-27
HUP0105148A3 (en) 2003-01-28
BG105654A (en) 2002-01-31
CO5150238A1 (es) 2002-04-29
TWI280241B (en) 2007-05-01
UA56358C2 (uk) 2003-05-15
SA99200838B1 (ar) 2006-03-06
EA003065B1 (ru) 2002-12-26
HRP20010514B1 (en) 2010-01-31
AU765081B2 (en) 2003-09-11
BG65027B1 (bg) 2006-12-29
CA2352436C (en) 2010-03-23
SK10202001A3 (sk) 2001-12-03
NZ513528A (en) 2003-08-29
EP1144386B1 (de) 2003-10-22
HK1041485B (zh) 2004-10-08
DE19901921A1 (de) 2000-08-03
JP2002535315A (ja) 2002-10-22
CN1144790C (zh) 2004-04-07
EE04344B1 (et) 2004-08-16
NO319823B1 (no) 2005-09-19
PL211829B1 (pl) 2012-06-29
HU227401B1 (en) 2011-05-30
KR100658959B1 (ko) 2006-12-19
IL143634A (en) 2006-10-05
CA2352436A1 (en) 2000-07-27
WO2000043370A1 (de) 2000-07-27
KR20010101552A (ko) 2001-11-14
NO20013560D0 (no) 2001-07-18
CZ297412B6 (cs) 2006-12-13
JP4700813B2 (ja) 2011-06-15
EP1144386A1 (de) 2001-10-17
CZ20012634A3 (cs) 2001-10-17
TR200102074T2 (tr) 2001-12-21
PT1144386E (pt) 2004-03-31

Similar Documents

Publication Publication Date Title
NO20013560L (no) Polymorfer av telmisartan, fremgangsmåter for fremstilling derav og anvendelse derav for fremstilling av et medikament
NO20031694L (no) Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
NO2013004I2 (no) Axitinib, valgfritt i form av et farmasøytisk aksentabelt salt
NO20035696D0 (no) Krystallinsk anti-cholinergikum, fremgangsmåte for fremstilling derav og anvendelse derav til fremstilling av et legemiddel
EE04497B1 (et) Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20015149D0 (no) Nytt farmasöytisk preparat
EE200100422A (et) Epotilooni derivaadid, nende valmistamismeetod jafarmatseutiline kasutamine
IS2174B (is) Setnar fenýl-píperasín afleiður, framleiðsla þeirra og notkun
NO20026212L (no) Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
DK1202996T3 (da) Titanforbindelser, fremstilling og anvendelse heraf
NO20015148L (no) Nytt farmasöytisk preparat
DE69941825D1 (de) Arzneistoffhaltiger kaugummi, dessen herstellungsverfahren und so erhaltene tablette
NO20033120L (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmåter for fremstilling derav og terapeutisk anvendelse derav
NO20015104D0 (no) Nytt farmasöytisk preparat
PT1200444E (pt) Novos compostos xantona, sua preparacao e sua utilizacao como medicamento
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
NO20015105D0 (no) Nytt farmasöytisk preparat
NO20021036L (no) Farmasöytisk preparat
IS6391A (is) 2-Arýlkínólín afleiður, framleiðsla og meðferðarleg notkun á þeim
DE60013337D1 (de) Rotierender Reibkörper und Methode zu dessen Herstellung
EE04871B1 (et) Dekstrasoksaani kasutamine, produkt ja meetod psoriaasi raviks m?eldud ravimi valmistamiseks
NO20016281D0 (no) Fremgangsmåte for fremstilling av legemiddel- mellomproduktforbindelser
UA33799A (uk) Спосіб одержання препарату інсуліну пролонгованої дії

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees